Depemokimab reviewed for asthma and CRSwNP in Asia January 28, 2025 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Irish government reduces stake in AIB Group to 12.5% Back: All Posts Next:Bluefield Solar maintains dividend at 2.20 pence per share